Pfizer, AstraZeneca COVID jabs 'highly effective' against India variant, study shows
The COVID-19 vaccines developed by Pfizer/BioNTech and AstraZeneca/Oxford University are "highly effective" against the Indian variant, a new study has found.Public Health England (PHE) said on Sunday that the Pfizer vaccine was 88 per cent…










